title: Safety of botulinum neurotoxin treatment in patients with chronic anal fissure.
authors.forename: Donatella
authors.initials: D
authors.lastname: Brisinda
authors.forename: Giorgio
authors.initials: G
authors.lastname: Maria
authors.forename: Riccardo
authors.initials: R
authors.lastname: Fenici
authors.forename: Ignazio Massimo
authors.initials: IM
authors.lastname: Civello
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Brisinda
mesh_terms: D000328:Adult; D001337:Autonomic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001342:Autonomic Nervous System Diseases / Q000139:chemically induced; D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002908:Chronic Disease; D005401:Fissure in Ano / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001337:Autonomic Agents; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A